02232nas a2200181 4500000000100000008004100001100001200042700001500054700001600069700001600085700001100101700001800112700001500130245009200145250001500237520174700252020005101999 2016 d1 aDias R.1 aPereira L.1 aHenschke N.1 aOliveira V.1 aDiz J.1 aLeopoldino A.1 aMartins V.00aPrevalence of low back pain in older Brazilians: a systematic review with meta-analysis a2016/04/143 a
INTRODUCTION: Prevalence of low back pain (LBP) is expected to increase worldwide with ageing of the population but its prevalence in older people is not clear, mainly in developing countries. OBJECTIVE: To estimate the prevalence of LBP in older Brazilians. METHODS: Electronic searches on SciELO, Lilacs, Medline, Embase and Cinahl, as well as hand-searching identified studies investigating prevalence of LBP in older Brazilians aged 60 years or older. Two independent reviewers selected studies fulfilling the inclusion criteria, assessed risk of bias for each included study and extracted relevant data. Meta-analysis was conducted when enough homogeneity allowed and the GRADE system was used to summarize the overall quality of the evidence. RESULTS: Sixteen studies were included with a total of 28,448 participants. Data from point- and period-prevalence of LBP were obtained. Meta-analysis was conducted for 13 studies reporting point-prevalence. Pooled point-prevalence of LBP was 25.0% (95% CI 18.0 to 32.0). Other three studies investigated period-prevalence: one-week prevalence = 15.0% (95% CI 13.0 to 18.0); six-month prevalence = 43.0% (95% CI 42.0 to 44.0); and 12-month prevalence = 13.0% (95% CI 11.0 to 16.0). Sensitivity analyses were performed for point-prevalence and exclusion of studies with poorer methodological quality tended to increase the estimated prevalence of LBP. CONCLUSION: Moderate-quality evidence show that at any point in time one in four older Brazilians suffers from LBP. This is the first systematic review investigating nationwide data on the prevalence of LBP in older people and contributes important clinical and epidemiological evidence for policymakers and health professionals.
a1809-4570 (Electronic)